PET scans revealed that the brains of patients with mild age-related memory loss who took the Alzheimer's drug Aricept exhibited increased metabolism rate and appeared more normal than the brains of patients given a placebo. The study suggests that treating early symptoms of memory loss may be beneficial, and that PET could be used to monitor the effectiveness of drugs given for the treatment of the condition.

Related Summaries